Gerami, Hadis
Mozaffari-Khosravi, Hassan
Mansour, Asieh
Sohrabpour, Amir Ali
Poustchi, Hossein
Hashemi Taheri, Amir Pejman
Jaafari, Mahmoud Reza
Jambarsang, Sara
Khayyatzadeh, Sayyed Saeid https://orcid.org/0000-0002-9133-7340
Article History
Received: 26 June 2025
Accepted: 24 September 2025
First Online: 30 October 2025
Declarations
:
: The authors declare no competing interests.
: This study was designed as a parallel-group, randomized, double-blind, placebo-controlled clinical trial (registration ID: IRCT20210427051098N2). It received ethical approval from the Institutional Review Board and the Research Ethics Committee of Shahid Sadoughi University of Medical Sciences (SSUMS), Yazd, Iran, on January 29, 2023 (approval ID: IR.SSU.SPH.REC.1401.157). All participants were informed about the study’s aims, procedures, potential risks, and benefits, and each provided written informed consent prior to enrollment.
: Not applicable.